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CLINICAL EFFECT OF IBUPROFEN AS AN ADJUNCT TO
NON-SURGICAL PERIODONTAL DISEASE TREATMENT
ABSTRACT: Twenty-five patients with progresive periodontal disease entered this
study in order to examine clinical effects of a non-steroidal anti-inflammatory drug — ibu-
profen, used as an adjunct to non-surgical periodontal treatment. After scaling and root pla-
ning, patients were randomly assigned to either receive orally 200 mg of ibuprofen per day
for one month (group A), or not receive the drug (group B). The obtained results show that
the mechanical periodontal treatment brought to resolution the gingival inflammation with
both group of patients. Although the mean values of the used indices were lower in group A
than in group B, those differences were neither statistically nor clinically significant. We
may conclude that systemic ibuprofen had no significant effect on plaque, gingival or blee-
ding index scores.
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INTRODUCTION
Bacteria and bacterial products have been considered for a century to be
of primary importance in the etiology of periodontal disease. Over the past
two decades, however, it has become evident that their presence alone is not
sufficient to clarify the pathophysiological mechanisms of periodontal tissue
destruction.
More recently, several studies have emphasized the role of the host's
immunoinflammatory responses during the destruction of periodontal tissues.
Evidence suggests that arachidonic acid metabolites are implicated as leading
biochemical mediators in the periodontal tissue destruction. Arachidonic acid
is a polyunsaturated fatty acid that is liberated from membrane phospholipids
of the cells involved in inflammatory reaction. By enzyme cyclooxigenase free
arachidonic acid is oxydized to prostanoides, which include prostaglandins,
prostacyclin and tromboxane, metabolites with potent biological activities. Re-
cent data support the concept that one of the distinguishing host response mec-
hanisms which are associated with periodontal disease progression is the local
formation and secretion of prostaglandin E2 (PGE2) that has proinflammatory
properties and can stimulate bone resorption. Studies have shown positive cor-
77relation of PGE2 levels within the periodontal tissues and within gingival cre-
vicular fluid to the clinical expression of periodontal disease. Furthermore, ex-
amination of healthy and diseased human periodontal tissues suggests that lo-
cal production of arachidonic acid metabolites and PGE2 in particular is clo-
sely associated with periodontal status and it appears to reflect the disease ac-
tivity.
Inhibition of PGE2 synthesis can be achieved by using one of the three
major pharmacological approaches. The first approach is to stabilize cell mem-
brane, suppress the cellular degranulation and reduce the level of free arahido-
nic acid by exploiting the biochemical properties of steroids. The second ap-
proach is to prevent the oxidation of arachidonic acid and the subsequent hy-
drolysis to form PGE2 by using antioxidants. The third approach is the direct
inhibition of the enzyme cyclooxigenase through the action of non-steroidal
anti-inflammatory drugs.
The purpose of this study was to investigate clinical effects of ibuprofen,
one of the non-steroidal anti-inflammatory drugs, applied as an adjunct to con-
servative periodontal disease therapy.
MATERIAL AND METHODS
Twenty-five patients, fourteen males and eleven females, suffering from
periodontal disease entered this study. All of them received mechanical perio-
dontal treatment — dental plaque and supra and subgingival calculus removal.
After thorough scaling and root planing, patients were randomly assigned to
either receive orally 200 mg of ibuprofen per day for one month (group A), or
not receive the drug (group B). Oral hygiene instructions were given to both
group of patients and they were motivated for oral hygiene. Plaque index
(Green-Vermillion), gingivitis index (Ramfjord) and gingival bleeding index
(Cowell) were used to assess the periodontal status of the patients. The criteria
for scoring were as follows:
Plaque index:
0 = no plaque and calculus on tooth surfaces
1 = plaque and calculus on the gingival third of tooth surface
2 = plaque and calculus on the middle third of tooth surface
3 = plaque and calculus on the incisal third of tooth surface
Gingivitis index:
0 = absence of signs of inflammation
1 = mild to moderate inflammation, not extending around the tooth
2 = mild to moderately severe inflammation, extending all around the tooth
3 = severe gingivitis with tendency to bleeding and ulceration
Gingival bleeding index:
0 = no bleeding on probing
1 = bleeding within 30 sec. after probing
782 = bleeding immediately after probing
3 = spontaneous bleeding
Patients were examined, and data were collected at the baseline, and then
once each of the four consecutive weeks after the mechanical treatment.
RESULTS
The obtained results showed that mechanical periodontal treatment bro-
ught to resolution the gingival inflammation with both group of patients. The
mean values of periodontal indices used in this study remained significantly
low throughout the examination period but with constant increase. Although
the mean values of plaque, gingivitis and gingival bleeding index were lower
in group A than in group B, the differences were not statistically significant.
The reason for that could be a small number of examinees but, in our opinion,
those differences were not clinically significant either. The reason could also
be the low dose of the drug, or it could be the low anti-inflammatory effect of
the systemically administrated ibuprofen on gingival tissues. Nevertheless, it
can be stated that in our study, no clinical effect of systemic ibuprofen was
observed.
Table 1. — Gingival bleeding index
Week of examination Group A Group B p
0 1.41 1.41 p > 0.05
I 0.75 0.82 p > 0.05
II 0.71 0.78 p > 0.05
III 0.78 0.81 p > 0.05
IV 0.82 0.89 p > 0.05
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Figure 1. — Plaque index — the bars represent mean values
for each week of the examination periodDISCUSSION
A number of studies, involving both humans and animals, have been con-
ducted to investigate the effects of non-steroidal anti-inflammatory drugs on
periodontal disease progression. The results of most of these studies have
shown beneficial effects of these drugs on gingival crevicular fluid levels of
PGE2, and on bone loss as well.
Investigating the effects of different non-steroidal anti-inflammatory drugs
on experimental periodontitis in beagle dogs, Offenbacher e ta l .(1992)
reported a significant decrease in the gingival crevicular fluid levels of PGE2
in all non-steroidal anti-inflammatory drug-treated animal groups [5]. Abram-
s o n et al. (1992) analyzed the clinical and biochemical effects of systemic
flurbiprofen on gingivitis in humans. They concluded that gingival crevicular
fluid levels of PGE2 were significantly decreased in flurbiprofen-treated pati-
ents when compared with the placebo group. One week after drug administra-
tion was discontinued, PGE2 levels returned to baseline levels [1]. Heas-
m a n et al. (1993), who also investigated effects of systemic flurbiprofen on
experimental gingivitis in 21 patients, reported similar results [2]. Jeffcoat
et al. (1988) reported of significantly lower bone resorption in 15 patients who
received 50 mg flurbiprofen for two months. Several other investigators repor-
ted significant bone gain in non-steroidal anti-inflammatory drug treated group
of patients [3].
At the same time, studies to correlate these positive effects of non-steroi-
dal anti-inflammatory drugs on gingival crevicular fluid levels of PGE2 and on
bone loss, with clinical effects such as plaque scores, gingival and bleeding in-
dex scores, often had contradictory results. While Haesman and coworkers, for
example, stated that the reduction of gingival crevicular fluid levels of PGE2
coincidences with clinically reduced gingival bleeding scores, several other in-
vestigators reported opposite results. Vogel e t a l . (1984) investigated the
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Figure 2. — Gingivitis index — the bars represent mean values
for each week of the examination periodeffects of systemic sulindac on experimental gingivitis in 18 male dental stu-
dents and concluded that there was no significant effect on gingival crevicular
flow and bleeding index [6]. Johanson e t a l . (1990) investigated the ef-
fects of naproxen, another non-steroidal anti-inflammatory drug, on gingival
inflammation. The results of their study showed that the drug had no signifi-
cant effect on plaque, gingival and bleeding index scores. A significant effect
of naproxen was only seen in resolution of gingivitis after plaque was remo-
ved [4].
The results of our study are close to these findings. It seems that, clini-
cally, non-steroidal anti-inflammatory drugs do not lead to a potent anti-in-
flammatory effect. Rather, they appear to stabilize the existing periodontal
condition and diminish or inhibit the rate of disease progression.
CONCLUSION
The results of this study showed no clinical benefit of systemically admi-
nistrated ibuprofen used as an adjunct to non-surgical periodontal therapy.
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Rezime
Bakterije i bakterijski produkti se veã dugi niz godina oznaåavaju kao
glavni uzroånici parodontalne bolesti. Meðutim, danas je jasno da i drugi me-
hanizmi, pre svega imuni odgovor domaãina, igraju veliku ulogu u destrukciji
parodontalnih tkiva. Istraÿivawa su pokazala da arahidonska kiselina i we-
ni metaboliti, a pre svih prostaglandin E2, imaju znatan inflamatorni po-
tencijal i da dovode do resorpcije alveolarne kosti. Rezultati mnogih studija
pokazuju da primena nesteroidnih antiinflamatornih lekova dovodi do smawe-
wa nivoa prostaglandina E2 u gingivalnoj teånosti i do smawewa koštane re-
sorpcije.
Ovo istraÿivawe preduzeto je sa ciqem da se ispita uticaj ibuprofena,
jednog od nesteroidnih antiinflamatornih lekova, kao dopune konzervativnoj
terapiji parodontalne bolesti, na kliniåki nalaz na parodoncijumu. Dvadeset
petoro pacijenata je nakon konzervativne terapije podeqeno u dve grupe. Paci-
jenti grupe A uzimali su svakodnevno tokom mesec dana 200 mg ibuprofena, dok
pacijenti grupe B nisu primali nikakvu medikaciju. Rezultati su pokazali da
je kod pacijenata obe grupe, nakon uklawawa supra- i sub-gingivalnih naslaga
i obrade parodontalnih xepova, došlo do znaåajnog smawewa inflamacije gin-
give. Izmeðu, pak, sredwih vrednosti plak indeksa, gingivalnog indeksa i in-
deksa krvarewa gingive pacijenata dve ispitivane grupe nije bilo statistiåki
a, po našem mišqewu, ni kliniåki znaåajnih razlika. Stoga zakquåujemo da
ibuprofen nije imao znaåajniji pozitivan uticaj na kliniåki nalaz na paro-
doncijumu kod ovih pacijenata.
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